Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enhancer of yellow 2 homolog pseudogene (ENSG00000234044) is a non-functional DNA sequence related to the functional ENY2 gene. Pseudogenes generally arise through gene duplication or retrotransposition but acquire mutations or lose regulatory elements that prevent them from producing functional protein. While most pseudogenes do not serve as canonical therapeutic or diagnostic targets and are not expressed as functional proteins, rare pseudogenes may affect gene regulation or disease processes via non-coding RNA functions. There is no evidence that ENSG00000234044 functions as a therapeutic target, interacts with drugs, or serves as a disease biomarker. Its main significance is in genomics and gene evolution studies, not clinical research or molecular pharmacology[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enhancer of yellow 2 homolog pseudogene (ENSG00000234044).